ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 143 filers reported holding ANI PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $796 | +27.4% | 13,718 | +18.2% | 0.00% | +100.0% |
| Q2 2023 | $625 | +43.0% | 11,607 | +5.4% | 0.00% | 0.0% |
| Q1 2023 | $437 | -13.8% | 11,016 | -13.0% | 0.00% | 0.0% |
| Q4 2022 | $507 | -99.9% | 12,662 | +4.2% | 0.00% | 0.0% |
| Q3 2022 | $390,000 | +8.3% | 12,152 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $360,000 | +15.8% | 12,152 | +12.5% | 0.00% | 0.0% |
| Q1 2022 | $311,000 | -26.5% | 10,806 | +17.1% | 0.00% | 0.0% |
| Q4 2021 | $423,000 | +55.5% | 9,228 | +12.4% | 0.00% | 0.0% |
| Q3 2021 | $272,000 | -5.2% | 8,211 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $287,000 | -2.7% | 8,211 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $295,000 | +7.3% | 8,211 | -13.4% | 0.00% | 0.0% |
| Q4 2020 | $275,000 | -9.2% | 9,486 | -11.6% | 0.00% | 0.0% |
| Q3 2020 | $303,000 | -12.7% | 10,732 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $347,000 | -29.6% | 10,732 | -11.9% | 0.00% | 0.0% |
| Q1 2020 | $493,000 | -28.2% | 12,175 | +8.5% | 0.00% | 0.0% |
| Q4 2019 | $687,000 | -11.7% | 11,222 | +5.1% | 0.00% | -50.0% |
| Q3 2019 | $778,000 | -17.1% | 10,675 | -6.6% | 0.00% | 0.0% |
| Q2 2019 | $939,000 | +11.3% | 11,426 | -4.6% | 0.00% | 0.0% |
| Q1 2019 | $844,000 | +68.8% | 11,982 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $500,000 | -16.1% | 11,982 | +13.4% | 0.00% | 0.0% |
| Q3 2018 | $596,000 | -29.2% | 10,569 | -16.2% | 0.00% | -50.0% |
| Q2 2018 | $842,000 | +14.7% | 12,614 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $734,000 | -9.6% | 12,614 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $812,000 | +24.9% | 12,614 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $650,000 | +10.2% | 12,614 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $590,000 | +2.8% | 12,614 | +8.6% | 0.00% | 0.0% |
| Q1 2017 | $574,000 | -18.5% | 11,614 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $704,000 | -54.3% | 11,614 | -50.0% | 0.00% | 0.0% |
| Q3 2016 | $1,542,000 | +164.0% | 23,228 | +122.2% | 0.00% | 0.0% |
| Q2 2016 | $584,000 | +11580.0% | 10,454 | +12495.2% | 0.00% | – |
| Q2 2015 | $5,000 | 0.0% | 83 | 0.0% | 0.00% | – |
| Q1 2015 | $5,000 | +25.0% | 83 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | +100.0% | 83 | 0.0% | 0.00% | – |
| Q3 2014 | $2,000 | -33.3% | 83 | 0.0% | 0.00% | – |
| Q2 2014 | $3,000 | 0.0% | 83 | 0.0% | 0.00% | – |
| Q1 2014 | $3,000 | +200.0% | 83 | 0.0% | 0.00% | – |
| Q4 2013 | $1,000 | 0.0% | 83 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 83 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |